Hepion Pharmaceuticals, Inc. SEC filings HEPA
Hepion Pharmaceuticals, Inc. has 723 filings in SEC EDGAR's recent list, going back to Aug 8, 2013. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (material agreement, acquisition or sale of assets, unregistered share sale, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 14, 2026 | — |
| S-8 | Employee stock plan registration | Aug 7, 2026 | — |
| 424B4 | Prospectus | Jan 23, 2025 | — |
| S-1MEF | Filing | Jan 21, 2025 | — |
| S-1/A | Amended registration statement | Jan 14, 2025 | — |
| S-1 | Registration statement | Dec 26, 2024 | — |
| 424B3 | Prospectus | Jul 15, 2024 | — |
| S-1 | Registration statement | Jul 11, 2024 | — |
| S-1 | Registration statement | Oct 31, 2023 | — |
| 424B5 | Prospectus supplement | Oct 2, 2023 | — |
| 424B5 | Prospectus supplement | Jul 21, 2023 | — |
| S-8 | Employee stock plan registration | Jul 14, 2023 | — |
| S-3/A | Filing | Nov 19, 2021 | — |
| S-3 | Shelf registration | Apr 2, 2021 | — |
| 424B5 | Prospectus supplement | Feb 16, 2021 | — |
| 424B5 | Prospectus supplement | Feb 16, 2021 | — |
| FWP | Free writing prospectus | Feb 12, 2021 | — |
| S-8 | Employee stock plan registration | Jan 19, 2021 | — |
| 424B4 | Prospectus | Nov 25, 2020 | — |
| S-1/A | Amended registration statement | Nov 20, 2020 | — |
| FWP | Free writing prospectus | Nov 18, 2020 | — |
| S-1/A | Amended registration statement | Nov 18, 2020 | — |
| FWP | Free writing prospectus | Nov 12, 2020 | — |
| S-1/A | Amended registration statement | Nov 12, 2020 | — |
| S-1 | Registration statement | Oct 29, 2020 | — |
| 424B5 | Prospectus supplement | Mar 27, 2020 | — |
| 424B5 | Prospectus supplement | Feb 12, 2020 | — |
| S-8 | Employee stock plan registration | Oct 21, 2019 | — |
| 424B4 | Prospectus | Jun 19, 2019 | — |
| S-1/A | Amended registration statement | Jun 12, 2019 | — |
| S-1/A | Amended registration statement | Jun 5, 2019 | — |
| S-1 | Registration statement | May 20, 2019 | — |
| 424B4 | Prospectus | Apr 26, 2019 | — |
| S-1/A | Amended registration statement | Apr 18, 2019 | — |
| S-3/A | Filing | Feb 13, 2019 | — |
| S-3 | Shelf registration | Feb 6, 2019 | — |
| S-1 | Registration statement | Jan 29, 2019 | — |
| 424B3 | Prospectus | Jun 22, 2018 | — |
| S-1MEF | Filing | Jun 22, 2018 | — |
| 424B4 | Prospectus | Jun 15, 2018 | — |
| S-1/A | Amended registration statement | Jun 13, 2018 | — |
| FWP | Free writing prospectus | Jun 5, 2018 | — |
| S-1/A | Amended registration statement | Jun 4, 2018 | — |
| S-1/A | Amended registration statement | May 31, 2018 | — |
| S-1 | Registration statement | May 18, 2018 | — |
| 424B5 | Prospectus supplement | Apr 25, 2017 | — |
| 424B5 | Prospectus supplement | Apr 24, 2017 | — |
| S-8 | Employee stock plan registration | Jan 23, 2017 | — |
| 424B5 | Prospectus supplement | Mar 30, 2016 | — |
| 424B5 | Prospectus supplement | Mar 30, 2016 | — |
| 424B5 | Prospectus supplement | Oct 7, 2015 | — |
| 424B5 | Prospectus supplement | Oct 6, 2015 | — |
| S-8 | Employee stock plan registration | May 4, 2015 | — |
| S-3 | Shelf registration | Mar 9, 2015 | — |
| S-1/A | Amended registration statement | Jun 2, 2014 | — |
| S-1 | Registration statement | May 12, 2014 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HEPA (OTC), CTRVP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Red Bank, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1583771
- Former names
- ContraVir Pharmaceuticals, Inc. (until Jul 23, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.